Concepedia

Olivier Bouché

OB

Statistics

Publications

5

Citations

2.2K

H-Index

5

Active since

2007

Affiliations

Inserm(Current)

Centre Hospitalier Universitaire de Reims

Université de Reims Champagne-Ardenne

Université Paris Cité

Olivier Bouché is an author at Inserm specializing in oncology, medicine, and malignant neoplasms.

Publications per year

2007–2019

5

Publications

5

Chemoradiation Followed by Surgery Compared With Chemoradiation Alone in Squamous Cancer of the Esophagus: FFCD 9102

Laurent Bedenne, Pierre Michel, Olivier Bouché et al. · Journal of Clinical Oncology · 2007 · 1.3K citations · Full text

Medicine, Oncology, Surgery +11

Analysis of <i>PTEN</i> , <i>BRAF</i> , and <i>EGFR</i> Status in Determining Benefit From Cetuximab Therapy in Wild-Type <i>KRAS</i> Metastatic Colon Cancer

Pierre Laurent‐Puig, Anne Cayre, Gilles Manceau et al. · Journal of Clinical Oncology · 2009 · 665 citations

Medicine, Oncology, Pharmacology +17

Pharmacogenetic Assessment of Toxicity and Outcome in Patients With Metastatic Colorectal Cancer Treated With LV5FU2, FOLFOX, and FOLFIRI: FFCD 2000-05

Valérie Boige, Jean Mendiboure, Jean‐Pierre Pignon et al. · Journal of Clinical Oncology · 2010 · 169 citations · Full text

Medicine, Oncology, Pharmacology +17

Sorafenib alone vs. sorafenib plus GEMOX as 1st-line treatment for advanced HCC: the phase II randomised PRODIGE 10 trial

Eric Assénat, Georges‐Philippe Pageaux, Simon Thézenas et al. · British Journal of Cancer · 2019 · 53 citations · Full text

Medicine, Oncology, Pharmacology +16

BRAF V600E Gene Mutation in Colonic Adenocarcinomas. Immunohistochemical Detection Using Tissue Microarray and Clinicopathologic Characteristics

Camille Boulagnon‐Rombi, Oriane Dudez, Olivia Beaudoux et al. · Applied immunohistochemistry & molecular morphology · 2015 · 10 citations

Medicine, Oncology, Pathology +17

1–5 of 5